Search
Search Results
- Publication:
- [Boston, Massachusetts] : Institute for Clinical and Economic Review, August 3, 2018
- Subject(s):
- Endometriosis -- drug therapy
Gonadotropin-Releasing Hormone -- antagonists & inhibitors
Analgesics -- adverse effects
Analgesics -- therapeutic use
Cost-Benefit Analysis
Pain -- drug therapy
Randomized Controlled Trials as Topic
Treatment Outcome
Humans
United States
- Publication:
- [Boston, Massachusetts] : Institute for Clinical and Economic Review, October 4, 2018
- Subject(s):
- Androgen Antagonists -- therapeutic use
Prostatic Neoplasms -- drug therapy
Androgen Antagonists -- adverse effects
Cost-Benefit Analysis
Disease Progression
Randomized Controlled Trials as Topic
Treatment Outcome
Humans
United States
- Publication:
- [Boston, Massachusetts] : Institute for Clinical and Economic Review, November 25, 2018
- Subject(s):
- Angioedemas, Hereditary -- drug therapy
Angioedemas, Hereditary -- prevention & control
Antibodies, Monoclonal, Humanized -- therapeutic use
Complement C1 Inhibitor Protein -- therapeutic use
Kallikreins -- antagonists & inhibitors
Antibodies, Monoclonal, Humanized -- adverse effects
Antibodies, Monoclonal, Humanized -- economics
Complement C1 Inhibitor Protein -- adverse effects
Complement C1 Inhibitor Protein -- economics
Cost-Benefit Analysis
Randomized Controlled Trials as Topic
Treatment Outcome
Humans
United States
- Publication:
- Silver Spring, MD : Center for Drug Evaluation and Research, May 2023
- Subject(s):
- Biological Products
Drug Industry
Government Regulation
Pharmaceutical Preparations
Randomized Controlled Trials as Topic
United States
- Publication:
- Washington, D.C. : AARP Public Policy Institute, c2011
- Subject(s):
- Clinical Trials as Topic
Patient Selection
Randomized Controlled Trials as Topic
Aged
Aged, 80 and over
Chronic Disease
Cost-Benefit Analysis
Frail Elderly
Sample Size
Selection Bias
Humans
United States
